Clinical Trials on Saliva Microbiome in Norway

Total 17 results

University Hospital of North Norway

Completed

Distribution of FMT After Delivery by · Lower GI Endoscopy vs Enema With and Without Positioning of the Patient

Fecal Microbiota Transplantation

Norway
Oslo Metropolitan University
University of Oslo; Nofima; Mills DA

Completed

Effect of Fat Quality on Glycemic Regulation and Gut Microbiota After a Short-time Intervention in Healthy Individuals

Gut Microbiota | Satiety | Postprandial Blood Glucose

Norway
Institut Pasteur
City of Orsay

Terminated

Phages Dynamics and Influences During Human Gut Microbiome Establishment (METAKIDS)

Human Gut Microbiome Development

France
Oslo Metropolitan University
University of Oslo; Nofima; Mills DA

Completed

Intake of Beta-glucan and Postprandial Regulation of Blood Glucose Metabolism in Healthy Subjects

Gut Microbiota | Satiety | Post Prandial Blood Glucose

Norway
Ågot Aakra
University of Oslo; Norwegian School of Sport Sciences; Norwegian Olympic Sports...

Unknown

Oslo Footballplayers Iron Supplementation and Training (FIT) Study (Oslo-FIT)

Athletes | Endurance Performance | Microbiota | Iron | Hemoglobin | Intestinal Health

Norway
Norwegian University of Life Sciences
Karolinska Institutet; Oslo University Hospital; Haukeland University Hospital; Helse Nord-Trøndelag HF and other collaborators

Recruiting

Norwegian Microbiota Study in Anorexia Nervosa (NORMA)

Anorexia Nervosa | Diet | Microbiota | Mental Health Issue | Gastrointestinal Problems

Norway
University of Bergen

Unknown

Effectiveness of Three Different Oral Moisturizers in Palliative Care Patients.

Xerostomia

Norway
Lovisenberg Diakonale Hospital
University of Oslo

Completed

A Randomized Controlled Trial Evaluating the Effectiveness of a Salvia-based Mouthwash in Palliative Care

Xerostomia | Terminal Illness

Norway
Oslo University Hospital
University of Oslo; University Hospital, Akershus

Active, not recruiting

The Gut and Oral Bacteria, Atherosclerosis and Ischemic Stroke Study

Ischemic Stroke | Atherosclerosis | Microbiota

Norway
University of Tromso

Completed

Oral Health Literacy Tailored Communication

Periodontal Diseases | Streptococcal Infections | Dental Plaque | Sialorrhea | Dental Calculus | Lactobacillus Infection

Norway
Helse Stavanger HF
University of Oslo; University of Stavanger

Completed

Fatigue and Interleukin-1 (IL-1) Blockade in Primary Sjøgrens Syndrome

Fatigue | Primary Sjogren

Norway
Oslo University Hospital
European Organisation for Research and Treatment of Cancer - EORTC

Completed

International Validation of the QLQ-OH17 for Oral Health (QLQ-OH17)

Quality of Life | Cancer | Xerostomia | Adverse Effects | Late Effects

Norway, Netherlands, Sweden, Germany, United Kingdom, Greece, France, Israel, Italy, Poland
Merck Sharp & Dohme LLC

Recruiting

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Cervical Cancer | Small Cell Lung Carcinoma | Neuroendocrine Tumor | Advanced Solid Tumors | Mesothelioma | Vulvar Cancer | Cholangiocarcinoma | Bile Duct Cancer | Endometrial Cancer | Advanced Cancer | Cervical Carcinoma | Endometrial Carcinoma | Thyroid Carcinoma | Thyroid Cancer | Anal Cancer | Colorectal Carcinoma | Carcinoid... and other conditions

Canada, France, Germany, Italy, Mexico, Netherlands, Poland, Russian Federation, Taiwan, United States, Brazil, Colombia, Israel, Korea, Republic of, Norway, Philippines, South Africa, Spain, Australia, Denmark, Chile, Portugal, Peru
OncoC4, Inc.
National Cancer Institute (NCI)

Recruiting

Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (PRESERVE-001)

Cervical Cancer | Small Cell Lung Cancer | Adenoid Cystic Carcinoma | Metastatic Renal Cell Carcinoma | Metastatic Colorectal Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Non Small Cell Lung Cancer | Metastatic Breast Cancer | Advanced Solid Tumor | Metastatic Melanoma | Pancreas Cancer | Metastatic... and other conditions

United States, Australia
GlaxoSmithKline

Completed

Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome

Sjogren's Syndrome

Spain, France, Germany, Netherlands, United Kingdom, Sweden, Argentina, Italy, Canada, Norway
National Cancer Institute (NCI)

Active, not recruiting

Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Stage IV Hypopharyngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Laryngeal Squamous Cell Carcinoma AJCC v7 | Stage IVA Oropharyngeal Squamous... and other conditions

United States, Puerto Rico, South Africa
GlaxoSmithKline

Completed

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

United States, Puerto Rico

Clinical Trials on Saliva Microbiome in Norway

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations